A Tlr7 translocation accelerates systemic autoimmunity in murine lupus.

The y-linked autoimmune accelerating (yaa) locus is a potent autoimmune disease allele. Transcription profiling of yaa-bearing B cells revealed the overexpression of a cluster of X-linked genes that included Tlr7. FISH analysis demonstrated the translocation of this segment onto the yaa chromosome. The resulting overexpression of Tlr7 increased in vitro responses to Toll-like receptor (TLR) 7 signaling in all yaa-bearing males. B6.yaa mice are not overtly autoimmune, but the addition of Sle1, which contains the autoimmune-predisposing Slam/Cd2 haplotype, causes the development of fatal lupus with numerous immunological aberrations. B6.Sle1yaa CD4 T cells develop the molecular signature for T(FH) cells and also show expression changes in numerous cytokines and chemokines. Disease development and all component autoimmune phenotypes were inhibited by Sles1, a potent suppressor locus. Sles1 had no effect on yaa-enhanced TLR7 signaling in vitro, and these data place Sles1 downstream from the lesion in innate immune responses mediated by TLR7, suggesting that Sles1 modulates the activation of adaptive immunity in response to innate immune signaling.

[1]  M. Sioud.  Innate sensing of self and non-self RNAs by Toll-like receptors. , 2006, Trends in molecular medicine.

[2]  S. Akira,et al.  Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8 , 2005, The Journal of experimental medicine.

[3]  Chandra Mohan,et al.  Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays. , 2005, The Journal of clinical investigation.

[4]  S. Akira,et al.  RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement , 2005, The Journal of experimental medicine.

[5]  C. Mackay,et al.  Follicular B helper T cells in antibody responses and autoimmunity , 2005, Nature Reviews Immunology.

[6]  S. Akira,et al.  Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus , 2005, The Journal of experimental medicine.

[7]  T. Moll,et al.  Selective expansion of a monocyte subset expressing the CD11c dendritic cell marker in the Yaa model of systemic lupus erythematosus. , 2005, Arthritis and rheumatism.

[8]  E. Wakeland,et al.  Epistatic Suppression of Systemic Lupus Erythematosus: Fine Mapping of Sles1 to Less Than 1 Mb1 , 2005, The Journal of Immunology.

[9]  R. Copley,et al.  A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity , 2005, Nature.

[10]  E. Wakeland,et al.  Sle1ab Mediates the Aberrant Activation of STAT3 and Ras-ERK Signaling Pathways in B Lymphocytes1 , 2005, The Journal of Immunology.

[11]  T. Moll,et al.  Differential Role of Three Major New Zealand Black-Derived Loci Linked with Yaa-Induced Murine Lupus Nephritis1 , 2005, The Journal of Immunology.

[12]  A. Pertsemlidis,et al.  Association of extensive polymorphisms in the SLAM/CD2 gene cluster with murine lupus. , 2004, Immunity.

[13]  Kazuhiko Yamamoto,et al.  Dissection of the role of MHC class II A and E genes in autoimmune susceptibility in murine lupus models with intragenic recombination. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[14]  A. Marshak‐Rothstein,et al.  The stimulation of Toll-like receptors by nuclear antigens: a link between apoptosis and autoimmunity. , 2004, Rheumatic diseases clinics of North America.

[15]  S. Akira,et al.  Toll-like Receptor 9–Dependent and –Independent Dendritic Cell Activation by Chromatin–Immunoglobulin G Complexes , 2004, The Journal of experimental medicine.

[16]  Akiko Iwasaki,et al.  Recognition of single-stranded RNA viruses by Toll-like receptor 7. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[17]  S. Akira,et al.  Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8 , 2004, Science.

[18]  Shizuo Akira,et al.  Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA , 2004, Science.

[19]  P. Leder,et al.  Chromosome instability and tumor predisposition inversely correlate with BLM protein levels. , 2003, DNA repair.

[20]  B. Croker,et al.  Genetic interactions between susceptibility loci reveal epistatic pathogenic networks in murine lupus , 2003, Genes and Immunity.

[21]  M. Shlomchik,et al.  Activation of autoreactive B cells by CpG dsDNA. , 2003, Immunity.

[22]  T. Wirth,et al.  The Yaa Mutation Promoting Murine Lupus Causes Defective Development of Marginal Zone B Cells1 , 2003, The Journal of Immunology.

[23]  C. Mohan,et al.  Genetic Dissection of SLE , 2002, The Journal of experimental medicine.

[24]  H. Wagner,et al.  Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848 , 2002, Nature Immunology.

[25]  A. Krieg.  A role for Toll in autoimmunity , 2002, Nature Immunology.

[26]  M. Shlomchik,et al.  Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors , 2002, Nature.

[27]  S. Akira,et al.  Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway , 2002, Nature Immunology.

[28]  A. Ashworth,et al.  A short pseudoautosomal region in laboratory mice. , 2001, Genome research.

[29]  G. Peltz,et al.  Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus. , 2001, Immunity.

[30]  E. Wakeland,et al.  The genetics of complex autoimmune diseases: non-MHC susceptibility genes , 2001, Nature Immunology.

[31]  T. Behrens,et al.  Delineating the genetic basis of systemic lupus erythematosus. , 2001, Immunity.

[32]  D. Kono,et al.  The Role of αβ+ T Cells and Homeostatic T Cell Proliferation in Y-Chromosome-Associated Murine Lupus1 , 2001, The Journal of Immunology.

[33]  K. Blenman,et al.  Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[34]  B. Croker,et al.  Epistatic modifiers of autoimmunity in a murine model of lupus nephritis. , 1999, Immunity.

[35]  B. Croker,et al.  Genetic dissection of lupus pathogenesis: a recipe for nephrophilic autoantibodies. , 1999, The Journal of clinical investigation.

[36]  C. Mohan,et al.  Genetic dissection of Sle pathogenesis: Sle3 on murine chromosome 7 impacts T cell activation, differentiation, and cell death. , 1999, Journal of immunology.

[37]  C. Mohan,et al.  Genetic dissection of SLE pathogenesis. Sle1 on murine chromosome 1 leads to a selective loss of tolerance to H2A/H2B/DNA subnucleosomes. , 1998, The Journal of clinical investigation.

[38]  D. Kono,et al.  Loci predisposing to autoimmunity in MRL-Fas lpr and C57BL/6-Faslpr mice. , 1998, The Journal of clinical investigation.

[39]  B. Croker,et al.  Functional dissection of systemic lupus erythematosus using congenic mouse strains. , 1997, Journal of immunology.

[40]  R. Eisenberg,et al.  The Yaa gene‐mediated acceleration of murine lupus: Yaa− T cells from non‐autoimmune mice collaborate with Yaa+ B cells to produce lupus autoantibodies in vivo , 1995, European journal of immunology.

[41]  D. Ernst,et al.  Maturational changes in CD4+ cell subsets and lymphokine production in BXSB mice. , 1994, Journal of immunology.

[42]  S. Izui,et al.  Selective autoantibody production by Yaa+ B cells in autoimmune Yaa(+)- Yaa- bone marrow chimeric mice , 1991, The Journal of experimental medicine.

[43]  S. Izui,et al.  The Y chromosome from autoimmune BXSB/MpJ mice induces a lupus‐like syndrome in (NZW × C57BL/6)F1 male mice, but not in C57BL/6 male mice , 1988, European journal of immunology.

[44]  A. Steinberg,et al.  Studies of consomic mice bearing the Y chromosome of the BXSB mouse. , 1985, Journal of immunology.

[45]  J. Roths,et al.  A Y chromosome associated factor in strain BXSB producing accelerated autoimmunity and lymphoproliferation. , 1979, Arthritis and rheumatism.

[46]  A. Theofilopoulos,et al.  Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains , 1978, The Journal of experimental medicine.

[47]  E. Wakeland,et al.  The importance of epistatic interactions in the development of autoimmunity. , 2005, Novartis Foundation symposium.

[48]  S. Izui,et al.  Autoimmune accelerating genes, lpr and Yaa, in murine systemic lupus erythematosus. , 1990, Autoimmunity.